Previous 10 | Next 10 |
2023-03-11 08:45:00 ET Whether you're growing from $200,000 to $1 million or hoping to take $20,000 to $100,000 over a period of 10 years, you'll need an average 17.5% annual return. While this would amount to market-beating returns, all three companies below have market capitalizations...
2023-03-07 05:48:00 ET For over a year now, growth stocks have been under a lot of pressure. Since peaking in late 2021, the Nasdaq Composite has fallen around 27%, and many of its components have fared much worse. For example, shares of Doximity (NYSE: DOCS) and SoFi Tech...
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023, at 9:15 a.m. Eastern Time/6:15 a.m Pacific Time. Abo...
2023-03-06 05:30:00 ET Doximity (NYSE: DOCS) has wowed investors with its solid list of customers, earnings growth, and top market position. The company offers doctors a platform to connect with colleagues, share patients' medical records, catch up on the latest news in their specia...
Artificial intelligence (AI) has been a hot topic this year with ChatGPT growing in popularity and people using the chatbot for a broad range of queries -- and even, in some cases, to help do their work for them, such as writing essays or coding. There's a lot of potential for AI to help impr...
Doximity (NYSE: DOCS) is on a roll. It's just not a good one. Shares of the digital healthcare platform for medical professionals have lost two-thirds of their value since hitting a high in the fourth quarter of 2021. Things were looking up earlier this year. However, Doximity gave up...
If you want growth for a dirt cheap price, look no further than some of the healthcare industry's most innovative players, like Teladoc Health (NYSE: TDOC) and Doximity (NYSE: DOCS) . Teladoc is a leader in the high-growth area of telemedicine. And Doximity is a platform that conn...
Healthcare software company Doximity (NYSE: DOCS) is showing signs it's back on the path to sustainable growth. The stock is up some 60% since its November 2022 lows, and though the latest quarterly earnings update was a mixed bag, there was plenty of good news to justify the rally. E...
Summary Doximity is the most used healthcare social platform in the US, with over 2 million users. Doximity’s business model represents both its biggest strength and threat being excessively focused on a small niche. Despite being expected to triple its revenues and maintain ...
The reviews for healthcare tech solutions provider Doximity 's (NYSE: DOCS) latest quarterly report came in this week in the form of analysts' price target adjustments. Some of these targets were raised and some were lowered, but ultimately, prognosticators who follow the company rema...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...